The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster
- PMID: 23600567
- PMCID: PMC3784163
- DOI: 10.1111/imm.12116
The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster
Abstract
Pathogenic New World hantaviruses cause severe disease in humans characterized by a vascular leak syndrome, leading to pulmonary oedema and respiratory distress with case fatality rates approaching 40%. Hantaviruses infect microvascular endothelial cells without conspicuous cytopathic effects, indicating that destruction of the endothelium is not a mechanism of disease. In humans, high levels of inflammatory cytokines are present in the lungs of patients that succumb to infection. This, along with other observations, suggests that disease has an immunopathogenic component. Currently the only animal model available to study hantavirus disease is the Syrian hamster, where infection with Andes virus (ANDV), the primary agent of disease in South America, results in disease that closely mimics that seen in humans. Conversely, inoculation of hamsters with a passaged Sin Nombre virus (SNV), the virus responsible for most cases of disease in North America, results in persistent infection with high levels of viral replication. We found that ANDV elicited a stronger innate immune response, whereas SNV elicited a more robust adaptive response in the lung. Additionally, ANDV infection resulted in significant changes in the blood lymphocyte populations. To determine whether the adaptive immune response influences infection outcome, we depleted hamsters of CD4(+) and CD8(+) T cells before infection with hantaviruses. Depletion resulted in inhibition of virus-specific antibody responses, although the pathogenesis and replication of these viruses were unaltered. These data show that neither hantavirus replication, nor pathogenesis caused by these viruses, is influenced by the adaptive immune response in the Syrian hamster.
Keywords: T cells; hantavirus; hantavirus cardiopulmonary syndrome; infectious disease; zoonosis.
Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Figures
Similar articles
-
Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.J Virol. 2014 Aug;88(15):8319-31. doi: 10.1128/JVI.00004-14. Epub 2014 May 14. J Virol. 2014. PMID: 24829335 Free PMC article.
-
Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.Virology. 2004 Aug 15;326(1):130-9. doi: 10.1016/j.virol.2004.05.018. Virology. 2004. PMID: 15262501
-
Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.J Virol. 2016 Jun 24;90(14):6200-6215. doi: 10.1128/JVI.00304-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27099308 Free PMC article.
-
The Syrian hamster model of hantavirus pulmonary syndrome.Antiviral Res. 2012 Sep;95(3):282-92. doi: 10.1016/j.antiviral.2012.06.002. Epub 2012 Jun 15. Antiviral Res. 2012. PMID: 22705798 Free PMC article. Review.
-
Hantavirus pulmonary syndrome.Virus Res. 2011 Dec;162(1-2):138-47. doi: 10.1016/j.virusres.2011.09.017. Epub 2011 Sep 17. Virus Res. 2011. PMID: 21945215 Review.
Cited by
-
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.bioRxiv [Preprint]. 2021 Jul 12:2021.07.11.451964. doi: 10.1101/2021.07.11.451964. bioRxiv. 2021. Update in: EBioMedicine. 2021 Nov;73:103675. doi: 10.1016/j.ebiom.2021.103675 PMID: 34268506 Free PMC article. Updated. Preprint.
-
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.Neuro Oncol. 2021 Nov 2;23(11):1911-1921. doi: 10.1093/neuonc/noab128. Neuro Oncol. 2021. PMID: 34059921 Free PMC article.
-
Maporal Hantavirus Causes Mild Pathology in Deer Mice (Peromyscus maniculatus).Viruses. 2016 Oct 18;8(10):286. doi: 10.3390/v8100286. Viruses. 2016. PMID: 27763552 Free PMC article.
-
Syrian Hamster as an Animal Model for the Study on Infectious Diseases.Front Immunol. 2019 Oct 1;10:2329. doi: 10.3389/fimmu.2019.02329. eCollection 2019. Front Immunol. 2019. PMID: 31632404 Free PMC article. Review.
-
Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma.Neurooncol Adv. 2023 Sep 28;5(1):vdad117. doi: 10.1093/noajnl/vdad117. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37841695 Free PMC article.
References
-
- Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol. 1995;26:110–20. - PubMed
-
- Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis. 1996;173:1297–303. - PubMed
-
- Elliott LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg. 1994;51:102–8. - PubMed
-
- Childs JE, Ksiazek TG, Spiropoulou CF, et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis. 1994;169:1271–80. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials